TrademarkDir
POLYGENRX
LIVE

Serial Number

79389137

Owner

PolygenRx Pty Ltd

Attorney

Fatima Y. Kassem

Filing Date

Jan 2, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

POLYGENRX Trademark

Serial Number: 79389137 • Registration: 7646725

POLYGENRX is a trademark filed by PolygenRx Pty Ltd on January 2, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PolygenRx Pty Ltd (2 trademarks)

81-83 Campbell Street

Entity Type: 82

Trademark Details

Filing Date

January 2, 2024

Registration Date

January 14, 2025

Published for Opposition

November 26, 2024

Goods & Services

Pharmaceutical research services; research relating to pharmaceuticals; research relating to medicine; scientific research relating to genetics; scientific research in the field of genetics; genetic research, namely, research in the field of genetic diseases and biological research in the field of genetic diseases.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 15, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 30, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 29, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 26, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 7, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 15, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 14, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 31, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 31, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 31, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 31, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 11, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 16, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 8, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 7, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 10, 2024 REPR

Related Trademarks

More from this Owner

PHARMAGENIC ENRICHMENT

PHARMAGENIC ENRICHMENT

PHARMAGENIC ENRICHMENT

PHARMAGENIC ENRICHMENT

PHARMAGENIC ENRICHMENT

PHARMAGENIC ENRICHMENT